查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
病理實驗室市場規模、份額和趨勢分析報告：按類型（醫院）、實驗室服務（一般生理學、臨床實驗室）、最終用戶（醫生推薦）、地區、細分市場預測 2022-2030 年
市場調查報告書
商品編碼
1147608

病理實驗室市場規模、份額和趨勢分析報告：按類型（醫院）、實驗室服務（一般生理學、臨床實驗室）、最終用戶（醫生推薦）、地區、細分市場預測 2022-2030 年

Pathology Laboratories Market Size, Share & Trends Analysis Report By Type (Hospital-based), By Testing Services (General Physiological & Clinical Tests), By End User (Physician Referrals) By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 79 Pages | 商品交期: 2-10個工作天內

價格

病理實驗室市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球病理實驗室市場預計將達到 6122 億美元。從 2022 年到 2030 年，該市場預計將以 7.86% 的複合年增長率增長。推動該行業的主要因素包括預期壽命延長、發展中國家醫療基礎設施改善、醫療費用優惠以及定期檢查需求增加。

此外，技術進步正在改變診斷的動態。創新技術使即時檢測 (POCT) 設備變得便攜，改進的取樣技術使診斷服務更容易獲得且更高效。通過通過質量、速度、效率和可擴展性來指導患者護理，預計會有幾項進展來改變行業。醫療保健系統越來越強調病理學和診斷實驗室成為更好的臨床決策引擎的重要性，幫助醫生更快、更準確地推理、診斷和監測患者。

COVID-19 大流行對病理學/診斷實驗室提出了很高的要求，因為在大流行期間需要對 COVID-19 進行檢測。 COVID-19感染的激增導致資金和測試的增加，推動了整個市場的增長。例如，美國 (NIH) 國立衛生研究院於 2020 年 9 月宣布，作為促進社區診斷計劃的一部分，將擴大對一套新的 COVID-19 檢測技術的製造支持，Maxim Biomedical 宣布 129.3 美元百萬的贈款給 9 個組織，包括 Inc、MatMaCorp 和 MicroGEM International。

病理實驗室市場報告要點

按類型劃分，醫院診斷實驗室在 2021 年主導了市場。這是因為醫院提供的先進測試是複雜診斷的最佳解決方案

由於成像技術的進步、事故的高發率和全球範圍內的目標疾病，預計成像與放射學部分在預測期內將增長最快。

就最終用戶而言，醫生轉診在 2021 年主導了市場。由於監控個人健康和福祉的自我意識增強，預計普通客戶和企業客戶將實現有利增長

預計美國對心血管健康診斷的需求很高，因為它是美國最突出的疾病

預計在預測期內，歐洲對腫瘤檢測的需求會很高。根據國際世界癌症研究基金會的數據，丹麥是世界上癌症患病率最高的國家。

最近，市場上出現了一些主要參與者之間的合作，希望為服務增加價值並擴大研究範圍。例如，2022 年 7 月，Unilab 宣布與 Subtle Medical 建立合作夥伴關係，成為第一家採用該公司基於 AI 的 MRI 技術提供高質量、快速 MRI 的診斷公司。該解決方案將首先在瑞典推出。

內容

第 1 章調查方法及範圍

  • 區域範圍
  • 調查方法
    • 資訊採購
      • 購買的數據庫
      • GVR 內部數據庫
      • 次要資訊
      • 初步調查
      • 初步調查的詳細資訊
  • 資訊或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細資訊
    • 商品流分析
    • 批量價格分析
  • 二級資訊列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場展望
  • 細分市場展望
  • 區域展望
  • 競爭考慮

第 3 章市場變量、趨勢和範圍

  • 市場動態
    • 市場促進因素分析
      • 改善新興國家/地區的醫療保健基礎設施
      • 對定期健康檢查的需求不斷增加
      • 用於診斷服務的禮服退款
    • 市場抑制因素分析
      • 高端分子診斷的價格實惠
      • 缺乏熟練勞動力
  • 商業環境分析工具
    • 波特的五力分析
      • 新進入者的威脅
      • 買家的議價能力
      • 競爭公司之間的敵對關係
      • 替代品的威脅
      • 供應商的議價能力
  • COVID-19 的影響
  • 監管框架和贖回方案

第 4 章病理實驗室市場：類型分析

  • 2021 年和 2030 年按類型分類的病理實驗室市場份額分析
  • 部門儀表板
  • 2017-2030 年類型市場規模及預測和趨勢分析
    • 基於醫院
    • 獨立實驗室
    • 診斷鍊

第 5 章病理實驗室市場：實驗室服務分析

  • 2021 年和 2030 年病理實驗室檢測服務市場份額分析
  • 部門儀表板
  • 2017-2030 年測試服務市場規模及預測和趨勢分析：
    • 一般生理和臨床檢查
    • 影像學和放射學
    • 奧術測試
    • COVID-19 測試

第 6 章病理實驗室市場：最終用途分析

  • 病理實驗室最終用途市場份額分析，2021 年和 2030 年
  • 部門儀表板
  • 2017-2030 年以下最終用途的市場規模和預測以及趨勢分析
    • 醫生介紹
    • 上門服務
    • 企業

第 7 章病理實驗室市場：區域分析

  • 病理實驗室區域市場份額分析，2021 年和 2030 年
  • 區域市場概況（市場規模，CAGR）
  • 2017-2030 年市場規模、預測和趨勢分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 意大利
      • 西班牙
      • 2017-203 年西班牙病理實驗室市場（十億美元）
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 中東和非洲
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 8 章競爭分析

  • 主要市場進入者的近期趨勢和影響分析
  • 競爭對手分類（主要創新者、市場領導者、初創企業）
  • 公司簡介
    • Quest Diagnostics Incorporated
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Eurofins Scientific
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Laboratory Corporation of America Holdings
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Exact Sciences Laboratories LLC
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Spectra Laboratories
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • SYNLAB International GmbH
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Sonic Healthcare Limited
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • DR Lal Path Labs.
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Metropolis Healthcare
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Kingmed Diagnostics
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Healius Limited
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • BioReference
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Centro de Diagnosticos
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Falco Holdings
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
    • Unilabs
      • 公司簡介
      • 財務業績
      • 服務基準
      • 戰略舉措
  • 供應商情況
    • Major Deals &Strategic Alliances
    • 公司市場分析
Product Code: GVR-4-68039-987-6

Pathology Laboratories Market Growth & Trends:

The global pathology laboratories market is expected to reach USD 612.2 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.86% from 2022 to 2030. The major factors driving the industry include increasing life expectancy, the development of healthcare infrastructure in developing nations, favoring reimbursement, and rising demand for routine medical check-ups.

In addition, the advancement of technology is altering the dynamics of diagnosis. Innovative technologies have made Point of Care Testing(POCT) devices portable and improved sampling techniques, making diagnostic services more accessible and efficient. Several advancements are expected to transform the industry by steering patient care through quality, speed, efficiency, and scalability. The healthcare system is progressively emphasizing the importance of pathological & diagnostic labs in becoming a greater clinical decision-making engine, assisting physicians in making inferences and diagnosing as well as monitoring patients more quickly and accurately.

The COVID-19 pandemic has resulted in higher demand for pathology/diagnostic labs as the testing for COVID-19 was necessary during the pandemic. The rapid rise of COVID-19 infections has resulted in increased funding and testing, which has boosted the overall market growth. For instance, the (NIH) National Institutes of Health in the United States announced in September 2020 that it would grant USD 129.3 million in funding to nine organizations including, Maxim Biomedical Inc., MatMaCorp, MicroGEM International, & others, for scaling-up manufacturing assistance to a new set of COVID-19 testing technologies as component of its initiative to boost diagnostics in the region.

Pathology Laboratories Market Report Highlights:

  • Based on type, hospital-based diagnostic labs dominated the market during the year 2021. This can be attributed to the advanced tests available at hospitals, making them the only best solution for complex diagnosis
  • The imaging & radiology tests segment is expected to have the fastest growth during the forecast period owing to the advancement in imaging techniques & the high prevalence of accidents & target diseases worldwide
  • Based on the end use, physician referrals dominated the market in 2021. Walk-in and corporate clients are expected to witness lucrative growth due to increased self-awareness for monitoring health and wellness among individuals
  • U.S. is expected to have a high demand for the diagnosis of cardiovascular health as a result of the most prominent disease in the U.S.
  • Europe is expected to have a high demand for oncology testing during the forecast period. Denmark has the highest prevalence of cancer globally in terms of cancer prevalence as per the World Cancer Research Fund International
  • The market is witnessing multiple collaborations in recent times with the key players aiming at adding value to their services & expanding their research. For Instance, in July 2022, Unilabs announced a partnership with Subtle Medical, to be the first diagnostic company to adopt their AI-based MRI technology for high-quality & quick MRI. The solution will be first launched in Sweden.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Regional Scope
  • 1.2 Estimates and Forecast Timeline
  • 1.3 Research Methodology
    • 1.3.1 Information procurement
      • 1.3.1.1 Purchased database
      • 1.3.1.2 GVR'S internal database
      • 1.3.1.3 Secondary sources
      • 1.3.1.4 Primary research
      • 1.3.1.4.1 Details of the primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
    • 1.6.2 Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective - 1
    • 1.9.2 Objective - 2
    • 1.9.3 Objective - 3

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Regional Outlook
  • 2.4 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Improving healthcare infrastructure in developing countries
      • 3.1.1.2 Increasing demand for regular general health check-ups
      • 3.1.1.3 Gowning reimbursement for diagnostics services
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Affordability for high-end molecular diagnostics
      • 3.1.2.2 Shortage of skilled workforce.
  • 3.2 Business Environment Analysis Tools
    • 3.2.1 Porter's Five Forces Analysis
      • 3.2.1.1 Threat of new entrants
      • 3.2.1.2 Bargaining power of buyers
      • 3.2.1.3 Competitive rivalry
      • 3.2.1.4 Threat of substitutes
      • 3.2.1.5 Bargaining power of suppliers
  • 3.3 Impact of COVID-19
  • 3.4 Regulatory Framework & Reimbursement Scenario

Chapter 4 Pathology Laboratories Market: Type Analysis

  • 4.1 Pathology Laboratories by Type Market Share Analysis, 2021 & 2030
  • 4.2 Segment Dashboard
  • 4.3 Market Size and Forecasts and Trend Analysis, 2017 - 2030 for the Type
    • 4.3.1 Hospital Based
      • 4.3.1.1 Hospital-based market, 2017 - 2030 (USD Billion)
    • 4.3.2 Standalone Labs
      • 4.3.2.1 Standalone labs market, 2017 - 2030 (USD Billion)
    • 4.4.3 Diagnostic Chains
      • 4.4.3.1 Diagnostic chains market, 2017 - 2030 (USD Billion)

Chapter 5 Pathology Laboratories Market: Testing Services Analysis

  • 5.1 Pathology Laboratories Testing Services Market Share Analysis, 2021 & 2030
  • 5.2 Segment Dashboard
  • 5.3 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for the Testing Services:
    • 5.3.1 General Physiological & Clinical Tests
      • 5.3.1.1 General physiological & clinical tests market, 2017 - 2030 (USD Billion)
    • 5.3.2 Imaging & Radiology Tests
      • 5.3.2.1 Imaging & radiology tests market, 2017 - 2030 (USD Billion)
    • 5.3.3 Esoteric Tests
      • 5.3.3.1 Esoteric tests market, 2017 - 2030 (USD Billion)
    • 5.3.4 COVID-19 Tests
      • 5.3.4.1 COVID-19 tests market, 2017 - 2030 (USD Billion)

Chapter 6 Pathology Laboratories Market: End-use Analysis

  • 6.1 Pathology Laboratories End-use Market Share Analysis, 2021 and 2030
  • 6.2 Segment Dashboard
  • 6.3 Market Size and Forecasts and Trend Analysis, 2017-2030 for the Following End-Use
    • 6.3.1 Physician Referrals
      • 6.3.1.1 Physician referrals market, 2017 - 2030 (USD Billion)
    • 6.3.2 Walk-Ins
      • 6.3.2.1 Walk-Ins market, 2017 - 2030 (USD Billion)
    • 6.3.3 Corporate
      • 6.3.3.1 Corporate market, 2017 - 2030 (USD Billion)

Chapter 7 Pathology Laboratories Market: Regional Analysis

  • 7.1 Pathology Laboratories Regional Market Share Analysis, 2021 & 2030
  • 7.2 Regional Market Snapshot (Market Size, CAGR)
  • 7.3 Market Size, & Forecasts, and Trend Analysis, 2017 to 2030
    • 7.3.1 North America
      • 7.3.1.1 North America pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.1.2 U.S.
      • 7.3.1.2.1 U.S. pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.1.3 Canada
      • 7.3.1.3.1 Canada pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.2 Europe
      • 7.3.2.1 Europe pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.2 U.K.
      • 7.3.2.2.1 UK pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.3 Germany
      • 7.3.2.3.1 Germany pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.4 France
      • 7.3.2.4.1 France pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.5 Italy
      • 7.3.2.5.1 Italy pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.2.6 Spain
      • 7.3.2.6.1 Spain pathology laboratories market, 2017 - 203 (0USD Billion)
    • 7.3.3 Asia Pacific
      • 7.3.3.1 Asia Pacific pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.2 Japan
      • 7.3.3.2.1 Japan pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.3 China
      • 7.3.3.3.1 China pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.4 India
      • 7.3.3.4.1 India pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.5 South Korea
      • 7.3.3.5.1 South Korea pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.3.6 Australia
      • 7.3.3.6.1 Australia pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.4 Latin America
      • 7.3.4.1 Latin America pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.4.2 Brazil
      • 7.3.4.2.1 Brazil pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.4.3 Mexico
      • 7.3.4.3.1 Mexico pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.4.4 Argentina
      • 7.3.4.4.1 Argentina pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.5 Middle East and Africa
      • 7.3.5.1 MEA pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.5.2 South Africa
      • 7.3.5.2.1 South Africa pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.5.3 Saudi Arabia
      • 7.3.5.3.1 Saudi Arabia pathology laboratories market, 2017 - 2030 (USD Billion)
      • 7.3.5.4 UAE
      • 7.3.5.4.1 UAE pathology laboratories market, 2017 - 2030 (USD Billion)

Chapter 8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.2 Competition Categorization (Key innovators, Market leaders, Emerging Players)
  • 8.3 Company Profiles
    • 8.3.1 Quest Diagnostics Incorporated
      • 8.3.1.1 Company overview
      • 8.3.1.2 Financial performance
      • 8.3.1.3 Service benchmarking
      • 8.3.1.4 Strategic initiatives
    • 8.3.2 Eurofins Scientific
      • 8.3.2.1 Company overview
      • 8.3.2.2 Financial performance
      • 8.3.2.3 Service benchmarking
      • 8.3.2.4 Strategic initiatives
    • 8.3.3 Laboratory Corporation of America Holdings
      • 8.3.3.1 Company overview
      • 8.3.3.2 Financial performance
      • 8.3.3.3 Service benchmarking
      • 8.3.3.4 Strategic initiatives
    • 8.3.4 Exact Sciences Laboratories LLC
      • 8.3.4.1 Company overview
      • 8.3.4.2 Financial performance
      • 8.3.4.3 Service benchmarking
      • 8.3.4.4 Strategic initiatives
    • 8.3.5 Spectra Laboratories
      • 8.3.5.1 Company overview
      • 8.3.5.2 Financial performance
      • 8.3.5.3 Service benchmarking
      • 8.3.5.4 Strategic initiatives
    • 8.3.6 SYNLAB International GmbH
      • 8.3.6.1 Company overview
      • 8.3.6.2 Financial performance
      • 8.3.6.2 Service benchmarking
      • 8.3.6.3 Strategic initiatives
    • 8.3.7 Sonic Healthcare Limited
      • 8.3.7.1 Company overview
      • 8.3.7.2 Financial performance
      • 8.3.7.2 Service benchmarking
      • 8.3.7.3 Strategic initiatives
    • 8.3.8 DR Lal Path Labs.
      • 8.3.8.1 Company overview
      • 8.3.8.2 Financial performance
      • 8.3.8.3 Service benchmarking
      • 8.3.8.4 Strategic initiatives
    • 8.3.9 Metropolis Healthcare
      • 8.3.9.1 Company overview
      • 8.3.8.2 Financial performance
      • 8.3.9.2 Service benchmarking
      • 8.3.9.4 Strategic initiatives
    • 8.3.10 Kingmed Diagnostics
      • 8.3.10.1 Company overview
      • 8.3.10.2 Financial performance
      • 8.3.10.2 Service benchmarking
      • 8.3.10.4 Strategic initiatives
    • 8.3.11 Healius Limited
      • 8.3.11.1 Company overview
      • 8.3.11.2 Financial performance
      • 8.3.11.2 Service benchmarking
      • 8.3.11.4 Strategic initiatives
    • 8.3.12 BioReference
      • 8.3.12.1 Company overview
      • 8.3.12.2 Financial performance
      • 8.3.12.2 Service benchmarking
      • 8.3.12.4 Strategic initiatives
    • 8.3.13 Centro de Diagnosticos
      • 8.3.13.1 Company overview
      • 8.3.13.2 Financial performance
      • 8.3.13.2 Service benchmarking
      • 8.3.13.4 Strategic initiatives
    • 8.3.14 Falco Holdings
      • 8.3.14.1 Company overview
      • 8.3.14.2 Financial performance
      • 8.3.14.2 Service benchmarking
      • 8.3.14.4 Strategic initiatives
    • 8.3.15 Unilabs
      • 8.3.15.1 Company overview
      • 8.3.15.2 Financial performance
      • 8.3.15.2 Service benchmarking
      • 8.3.15.4 Strategic initiatives
  • 8.4 Vendor Landscape
    • 8.4.1 Major Deals & Strategic Alliances
    • 8.4.1 Company Market Position Analysis

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviations
  • TABLE 3 Global pathology laboratories market, by Region, 2017 - 2030 (USD Billion)
  • TABLE 4 Global pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 5 Global pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 6 Global pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 7 North America pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 8 North America pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 9 North America pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 10 North America pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 11 U.S. pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 12 U.S. pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 13 U.S. pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 14 Canada pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 15 Canada pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 16 Canada pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 17 Europe pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 18 Europe pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 19 Europe pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 20 Europe pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 21 UK pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 22 UK pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 23 UK pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 24 Germany pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 25 Germany pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 26 Germany pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 27 France pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 28 France pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 29 France pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 30 Italy pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 31 Italy pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 32 Italy pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 33 Spain pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 34 Spain pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 35 Spain pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 36 Rest of Europe pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 37 Rest of Europe pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 38 Rest of Europe pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 39 Asia Pacific pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 40 Asia Pacific pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 41 Asia Pacific pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 42 Asia Pacific pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 43 China pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 44 China pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 45 China pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 46 Japan pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 47 Japan pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 48 Japan pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 49 India pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 50 India pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 51 India pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 52 South Korea pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 53 South Korea pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 54 South Korea pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 55 Australia pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 56 Australia pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 57 Australia pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 58 Rest of Asia Pacific pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 59 Rest of Asia Pacific pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 60 Rest of Asia Pacific pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 61 Latin America pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 62 Latin America pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 63 Latin America pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 64 Latin America pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 65 Brazil pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 66 Brazil pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 67 Brazil pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 68 Mexico pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 69 Mexico pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 70 Mexico pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 71 Argentina pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 72 Argentina pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 73 Argentina pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 74 Rest of Latin America pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 75 Rest of Latin America pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 76 Rest of Latin America pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 77 Middle East & Africa pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
  • TABLE 78 Middle East & Africa pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 79 Middle East & Africa pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 80 Middle East & Africa pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 81 South Africa pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 82 South Africa pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 83 South Africa pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 84 Saudi Arabia pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 85 Saudi Arabia pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 86 Saudi Arabia pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 87 UAE pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 88 UAE pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 89 UAE pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
  • TABLE 90 Rest of Middle East & Africa pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
  • TABLE 91 Rest of Middle East & Africa pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
  • TABLE 92 Rest of Middle East & Africa pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market outlook, 2021 (USD Billion)
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Pathology laboratories market: Type movement analysis (USD Billion)
  • FIG. 13 Pathology laboratories market Type Segment Dashboard
  • FIG. 14 Hospital-Based market, 2017 - 2030 (USD Billion)
  • FIG. 15 Standalone labs market 2017 - 2030 (USD Billion)
  • FIG. 16 Diagnostic chains market 2017 - 2030 (USD Billion)
  • FIG. 17 Pathology laboratories market: Testing Services movement analysis (USD Billion)
  • FIG. 18 Pathology laboratories market: Testing services segment dashboard
  • FIG. 19 General physiological & clinical tests market, 2017 - 2030 (USD Billion)
  • FIG. 20 Imaging & radiology market, 2017 - 2030 (USD Billion)
  • FIG. 21 Esoteric tests market, 2017 - 2030 (USD Billion)
  • FIG. 22 COVID-19 tests market, 2017 - 2030 (USD Billion)
  • FIG. 23 Pathology laboratories market: End-use movement analysis (USD Billion)
  • FIG. 24 Pathology laboratories market: End-use segment dashboard
  • FIG. 25 Physician referrals market, 2017 - 2030 (USD Billion)
  • FIG. 26 Walk-ins market, 2017 - 2030 (USD Billion)
  • FIG. 27 Corporate market, 2017 - 2030 (USD Billion)
  • FIG. 28 Regional outlook, (USD Billion)
  • FIG. 29 Regional market place: Key takeaways
  • FIG. 30 North America pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 31 U.S. pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 32 Canada pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 33 Europe pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 34 UK. pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 35 Germany pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 36 France pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 37 Italy pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 38 Spain pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 39 Asia Pacific pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 40 China pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 41 Japan pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 42 India pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 43 South Korea pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 44 Australia pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 45 Latin America pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 46 Brazil pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 47 Mexico pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 48 Argentina pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 49 MEA pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 50 South Africa pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 51 Saudi Arabia pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 52 UAE pathology laboratories market, 2017 - 2030 (USD Billion)
  • FIG. 53 Recent developments & impact analysis, by key market participants
  • FIG. 54 Company categorization
  • FIG. 55 Company market position analysis